At a glance
ClinicalIndex Comparison RecordN/ACompleted· 369 enrolled
Drug / intervention
Monovisc® +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate to Provide Symptomatic Relief of Osteoarthritis of the Knee
In Brief
A clinical study evaluating Monovisc® and Saline for Osteoarthritis. Completed, enrolled 369 participants across 31 sites in 2 countries.
Detailed Summary
The purpose of this study is to determine whether intra-articular injection of Monovisc® hyaluronic acid provides symptomatic relief of osteoarthritis of the knee.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesCanada, United States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
First PostedApr 2008
Primary CompletionDec 2009
Study CompletionFeb 2010
TodayJul 2026
First PostedApr 7, 2008
Enrollment StartJan 1, 2008
Primary CompletionDec 1, 2009
Study CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 18.2 years ago
Interventions
Monovisc®device
Intra-articular injection
Salineother
0.9% Sterile Saline